(19)
(11) EP 4 583 909 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23773170.8

(22) Date of filing: 05.09.2023
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; C12N 2770/20034; A61K 2039/70; A61P 31/14
(86) International application number:
PCT/EP2023/074314
(87) International publication number:
WO 2024/052336 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.09.2022 EP 22193939
26.05.2023 EP 23175846

(71) Applicant: Freie Universität Berlin
14195 Berlin (DE)

(72) Inventors:
  • TRIMPERT, Jakob
    10115 Berlin (DE)
  • KUNEC, Dusan
    10551 Berln (DE)
  • OSTERRIEDER, Nikolaus
    14482 Potsdam (DE)

(74) Representative: Maikowski & Ninnemann Patentanwälte Partnerschaft mbB 
Postfach 15 09 20
10671 Berlin
10671 Berlin (DE)

   


(54) A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF